Centrum 7/6  banner

Brian Griffin

Diplomat Pharmacy agrees to $300 million buyout by UnitedHealth

Diplomat Pharmacy agrees to $300 million buyout by UnitedHealth

FLINT, Mich. — UnitedHealth Group pharmacy benefit manager OptumRx on Monday announced plans to purchase specialty drug provider Diplomat Pharmacy Inc. for about $300 million. The news comes amid continued financial struggles for Diplomat. In the third quarter, the company reported a $177 million net loss. In a statement, Diplomat chairman and chief executive officer

Diplomat considers sale, merger

Diplomat considers sale, merger

FLINT, Mich. — Diplomat Pharmacy is considering a sale or merger after seeing revenue declines in its PBM and specialty segments in the second quarter ended June 30. The company’s board ordered the exploration of “strategic alternatives” after Diplomat’s quarterly revenue dropped 9% from the year-ago period to $1.29 billion. Besides a sale or merger,

Diplomat signs exclusive practice-based infusion agreement with Allergy Partners

Diplomat signs exclusive practice-based infusion agreement with Allergy Partners

FLINT, Mich. — Diplomat Pharmacy announced an exclusive agreement between Diplomat and Allergy Partners, P.A., to manage in-office and in-home delivery and administration of infusion drugs and biologics. The agreement will cover treatments for primary immunodeficiency, alpha-1 antitrypsin deficiency, hereditary angioedema, and more. Allergy Partners is the nation’s largest independent, single-specialty practice for allergic disease,

Diplomat announces second quarter results, to review strategic alternatives

Diplomat announces second quarter results, to review strategic alternatives

FLINT, Mich. — Diplomat Pharmacy announced financial results for the quarter ended June 30, 2019.   Revenue decreased 9% from $1.4 billion to $1.2 billion and gross profit decreased from $98.4 million to $72.7 million from the prior-year quarter. Adjusted EBITDA was $19.3 million compared to $42.7 million in the prior-year period, and earnings per share were

Diplomat provides updated 2018 guidance and preliminary 2019 outlook

Diplomat provides updated 2018 guidance and preliminary 2019 outlook

FLINT, Mich. — Diplomat Pharmacy is updating its 2018 financial guidance and providing a preliminary 2019 outlook in connection with its presentation today at the JP Morgan Healthcare Conference in San Francisco. Diplomat now expects 2018 revenue to be at the lower end of the previously communicated $5.5 to $5.7 billion range and adjusted EBITDA to be at

Diplomat goes green with new packaging from TemperPack

Diplomat goes green with new packaging from TemperPack

FLINT, Mich. — Diplomat Pharmacy is now shipping temperature-sensitive medication in ClimaCell coolers from TemperPack. ClimaCell coolers are fully recyclable at curbside and insulated with renewable materials that can be recycled wherever plastic bags are accepted. Diplomat previously used expanded polystyrene (EPS) foam coolers. Diplomat’s efforts will help divert more than five tons of plastic

Diplomat opens facility in Arizona

Diplomat opens facility in Arizona

FLINT, Mich. — Diplomat Pharmacy  has opened a 75,000-square-foot facility in Chandler, Ariz., to bolster pharmacy operations and ensure business continuity. Diplomat expects the location to create 200 local jobs over the next year. Chief executive officer and chairman Brian Griffin said the Chandler facility — 485 N. Juniper Drive — increases Diplomat’s capacity to serve more

Diplomat announces 2nd quarter financial results

Diplomat announces 2nd quarter financial results

FLINT, Mich. — Diplomat Pharmacy announced financial results for the quarter ended June 30, 2018.  All comparisons, unless otherwise noted, are to the quarter ended June 30, 2017.  Prior period financials have been recast to include certain direct expenses as part of cost of sales instead of selling, general and administrative expense (“SG&A”) for our specialty

Diplomat tabs Griffin chairman and CEO

Diplomat tabs Griffin chairman and CEO

FLINT, Mich. — The board of directors of Diplomat Pharmacy has appointed Brian Griffin board chairman and chief executive officer, effective June 4, the company announced last month. Griffin recently resigned as the executive vice president and CEO of IngenioRx, the pharmacy benefit manager of Anthem Inc. “We are pleased to welcome Brian to the

Diplomat Pharmacy names Griffin CEO

Diplomat Pharmacy names Griffin CEO

FLINT, Mich.— Diplomat Pharmacy Inc. announced that its board of directors has appointed Brian Griffin, executive vice president and chief executive officer of IngenioRx, the pharmacy benefit manager (PBM) of Anthem, as chief executive officer and chairman of the board of directors, effective June 4. Ben Wolin, chairman of the board, said, “We are pleased to

CVS Health to support new Anthem PBM

CVS Health to support new Anthem PBM

WOONSOCKET, R.I. — CVS Health has signed a five-year agreement to provide services to support IngenioRx, a new pharmacy benefit manager formed by Blue Cross Blue Shield health insurer Anthem Inc. CVS said Wednesday that its CVS Caremark PBM division will manage certain services for IngenioRx, including claims processing and prescription fulfillment. In addition, CVS

PP_1170x120_10-25-21